Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microalbuminuria

M Marre1, B Bouhanick, G Berrut

  • 1University Hospital, Angers, France.

Current Opinion in Nephrology and Hypertension
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Microalbuminuria, an early sign of kidney damage, predicts cardiovascular disease and kidney disease. Angiotensin-converting enzyme inhibitors show promise in preventing diabetic nephropathy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter to the Editor: Launch of a 2022-2024 National Plan Against Falls in Older Persons in France.

The journal of nutrition, health & aging·2023
Same author

Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports.

Diabetes & metabolism·2020
Same author

Relationship between renal capacity to reabsorb glucose and renal status in patients with diabetes.

Diabetes & metabolism·2020
Same author

Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10).

Diabetes & metabolism·2019
Same author

Dairy consumption is associated with lower plasma dihydroceramides in women from the D.E.S.I.R. cohort.

Diabetes & metabolism·2019
Same author

Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings.

Diabetes & metabolism·2019
Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
Same journal

Social determinants of chronic kidney disease: from association to clinical and population action.

Current opinion in nephrology and hypertension·2026
See all related articles

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Microalbuminuria signifies elevated urinary albumin excretion, often indicating early glomerulosclerosis.
  • It serves as a crucial predictor for diabetic nephropathy and premature cardiovascular mortality.

Purpose of the Study:

  • To highlight microalbuminuria as a key indicator of combined renal and cardiovascular risk.
  • To review treatment interventions targeting microalbuminuria.

Main Methods:

  • Literature review and analysis of studies using microalbuminuria as an endpoint.
  • Examination of risk factors, including genetic determinants, contributing to microalbuminuria.

Main Results:

  • Microalbuminuria is a strong predictor of nephropathy in insulin-dependent diabetes.

Related Experiment Videos

  • It also predicts cardiovascular mortality in non-insulin-dependent diabetes and the general population.
  • Angiotensin-converting enzyme inhibitors demonstrated efficacy in preventing nephropathy.

    • Conclusions:

    • Microalbuminuria is a valuable biomarker for summarizing renal and cardiovascular risk across diverse populations.
    • Early identification and intervention are crucial for managing conditions associated with microalbuminuria.